Table 1.
Basic Characteristics of Enrolling Patients
| Variables | Total Study Population | Without Death | with Death | P value |
|---|---|---|---|---|
| N=1550 | N=1418 | N=132 | ||
| Male, n(%) | 926(59.7) | 855(39.7) | 71(46.2) | 0.145 |
| BMI(kg/m2) | 24.97 ± 3.48 | 25.08 ± 3.51 | 24.07 ± 3.04 | <0.001 |
| Age(years) | 73.10 ± 8.57 | 72.50 ± 8.30 | 79.55 ± 8.78 | 0.818 |
| SBP(mmHg) | 138(120,156) | 139(121,157) | 132(109,141) | 0.001 |
| Diabetes, n(%) | 671(43.3) | 603(42.5) | 68(51.5) | 0.046 |
| Heart failure, n(%) | 1082(69.8) | 959(67.6) | 123(93.2) | <0.001 |
| Type of AMI | 0.048 | |||
| NSTEMI, n(%) | 1102(71.1) | 1018(71.8) | 84(63.6) | |
| STEMI, n(%) | 448(28.9) | 400(28.2) | 48(36.4) | |
| Previous stroke, n(%) | 125(8.1) | 108(7.7) | 16(12.1) | 0.068 |
| Hypertension, n(%) | 1079(69.6) | 994(70.1) | 85(64.3) | 0.173 |
| eGFR class | <0.001 | |||
| >60, n(%) | 1099(70.9) | 1054(74.3) | 45(34.1) | |
| 30~60, n(%) | 228(14.7) | 188(13.3) | 40(30.3) | |
| <30, n(%) | 223(14.4) | 176(12.4) | 47(35.6) | |
| Blood routine examination | ||||
| Neutrophils(109/L) | 5.18(3.93,7.04) | 5.01(3.85,6.63) | 8.96(5.87,12.34) | <0.001 |
| Lymphocytes(109/L) | 1.40(1.05,1.87) | 1.42(1.08,1.89) | 1.07(0.65,1.70) | <0.001 |
| WBC(109/L) | 7.50(0.5.93,9.36) | 7.32(5.86,9.02) | 10.85(8.14,14.39) | <0.001 |
| PLT(109/L) | 205(170,244) | 204.50(170.00,244.00) | 208.50(168.00,252.50) | 0.969 |
| Hb(g/L) | 130(116,142) | 131.00(117.75,142.00) | 117.50(103.25,132.75) | <0.001 |
| NLR | 3.61(2.43,5.83) | 3.43(2.37,5.29) | 7.74(4.71,14.66) | <0.001 |
| PLR | 143.02(107.28,196.92) | 140.07(106.06,189.93) | 185.85(122.81,284.66) | <0.001 |
| Laboratory data | ||||
| Na(mmol/L) | 140(137.89,141.90) | 140.10(138.02,141.92) | 138.90(135.52,141.00) | <0.001 |
| K(mmol/L) | 3.95(3.66,4.26) | 3.93(3.65,4.23) | 4.12(3.71,4.58) | <0.001 |
| ALT(U/L) | 23.07(15.00,37.29) | 22.57(14.96,36.34) | 28.77(16.28,62.95) | <0.001 |
| AST(U/L) | 29.16(19.56,75.73) | 27.83(19.26,66.00) | 75.40(29.04,206.57) | <0.001 |
| Triglycerides(mmol/L) | 1.31(0.96,1.83) | 1.33(0.96,1.85) | 1.17(0.93,1.71) | 0.048 |
| Total cholesterol(mmol/L) | 4.36(3.64,5.20) | 4.38(3.65,5.20) | 4.31(3.45,5.23) | 0.715 |
| LDL-C(mmol/L) | 2.41(1.85,3.04) | 2.42(1.86,3.04) | 2.27(1.73,3.09) | 0.331 |
| HDL-C(mmol/L) | 1.04(0.90,1.21) | 1.03(0.90,1.21) | 1.08(0.84,1.29) | 0.547 |
| CTNI(ug/L) | 1.05(0.55,3.46) | 0.98(0.52,2.58) | 5.26(0.85,20.22) | <0.001 |
| CK-MB(ug/L) | 19.76(14.84,43.05) | 19.59(15.00,40.13) | 22.25(6.10,96.19) | 0.867 |
| Inpatient medication | ||||
| Aspirin, n(%) | 1437(92.7) | 1324(93.4) | 113(85.6) | 0.001 |
| Statins, n(%) | 1512(97.5) | 1391(98.1) | 121(91.7) | <0.001 |
| β-blockers, n(%) | 896(57.8) | 833(58.7) | 63(47.7) | 0.014 |
| ACEI/ARBs, n(%) | 685(44.2) | 653(46.1) | 32(24.2) | <0.001 |
Abbreviations: BMI, body mass index; SBP, systolic blood press; NSTEMI, non-ST segment elevation myocardial infarction; STEMI, ST segment elevation myocardial infarction; eGFR, estimated glomerular filtration rate; WBC, white blood cell; PLT, platelet; Hb, hemoglobin; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; CTNI, cardiac troponin I; CK-MB creatine kinase-MB; ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers.